相关实验视频

Updated: Jun 6, 2025

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

An Automated Radiosynthesis of [⁶⁸Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

核医学中化合物链接器的比较长度以向纤维细胞激活蛋白作为分子标

Kentaro Hisada¹, Kazuko Kaneda-Nakashima^1,2, Yoshifumi Shirakami²

¹Radiation Biological Chemistry, MS-CORE, Forefront Research Center, Graduate School of Science, Osaka University, 1-1 Machikaneyama-cho, Toyonaka 560-0043, Osaka, Japan.

International journal of molecular sciences

|November 27, 2024

概括

研究人员比较了针对癌症的两个α-发射疗法.

科学领域:

核医学是一种核医学.
放射性药物疗法是一种放射性药物疗法.
癌症研究癌症研究

背景情况:

新的α-发射放射性药物正在出现用于癌症治疗.
纤维细胞激活蛋白α (FAPα) 是一个有前途的治疗点.
FAPI化合物为癌症管理提供了治疗能力.

研究的目的:

为了比较两个针对FAPα的化合物的疗效,211At-FAPI1和211At-FAPI2.
为了评估链条长度对瘤保留,分泌和抗瘤效应的影响.
评估3D培养系统对FAPα抑制剂体外查的有用性.

主要方法:

使用3D培养系统进行体外查.
采用了希拉卡米反应,以211At.At.快速放射标记FAPI化合物.
在体内比较211At-FAPI1和211At-FAPI2的瘤积累,分泌途径和抗瘤疗效.

主要成果:

翻倍FAPI化合物的链接长度增强了瘤保留.
观察到更长的链接器改变了分泌途径,这表明毒性降低了.
在211At-FAPI1和211At-FAPI2之间没有发现抗瘤作用的显著差异,但链接器的长度影响了生物半衰期.

结论:

链接器的长度是影响FAPα向放射性药物的药理学特性的一个关键因素.
3D培养系统显示出FAPα抑制剂体外查的前景.
进一步优化链接器长度可能会改善治疗结果,并减少基于FAPI的治疗药物中的毒性.

关键词:

在-211的at-211上 FAPIAPI FAPIAPI 这是一个很好的方法.FAPα是指FAPα的一种类型.中间分子中间分子核医学是核医学的一种.

更多相关视频

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...